相关实验视频

Updated: Jul 6, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

血脂概况的变化与腹腔透析患者对Roxadustat的治疗反应有关

Ya-Hui Yang¹, Yishakejiang Saimaiti^1,2, Yang Zhao²

¹Department of Nephrology, Peking University Third Hospital, Beijing, China.

Frontiers in physiology

|January 8, 2024

概括

催氧诱导因子酸酶抑制剂 (HIF-PHI) 治疗,如Roxadustat,在腹腔透析患者中降低了脂和脂代谢. 这种代谢转变与贫血的改善有关,这表明除了红色素形成之外还有更广泛的治疗效果.

科学领域:

生物化学生化学
腎臟病學 (nephrology) 是一種醫學專業.
药理学药理学是指药理学的学科.

背景情况:

脂 (PL) 和脂 (SM) 代谢升高与腹透析 (PD) 末期病 (ESKD) 患者的不良结果有关.
众所周知,像Roxadustat这样的低氧诱导因子基酶抑制剂 (HIF-PHI),会影响脂质代谢.
在HIF-PHI治疗后调查PL和SM代谢的变化,可以阐明其影响超出了PD患者的贫血纠正.

研究的目的:

评估Roxadustat (HIF-PHI) 对稳定PD患者的脂和脂代谢的影响.
探索HIF-PHI治疗后脂质代谢变化和贫血纠正之间的关系.

主要方法:

稳定的PD患者接受Roxadustat超过三个月被纳入.
在Roxadustat治疗前后量化了脂和脂代谢标志物.
进行统计分析,包括回归,以评估治疗效应和相关性.

主要成果:

25名PD患者完成了这项研究.
HIF-PHI治疗导致脂和脂代谢的总体下降趋势.
在特定的代谢物中观察到显著的减少,包括LysoPC (20:0),CisPC (DLPC) (18:2),LysoPE (14:0),和斯芬戈米林 (d18:1/17:0) (17:0) (p <0.05).
血红蛋白水平的增加与各种酸乙醇胺 (PE),酸乙醇胺 (LysoPE) 和酸胆 (PC) 的水平下降有显著的相关性.

结论:

给予HIF-PHI (Roxadustat) 降低了PD患者的脂和脂代谢.
这些代谢变化与贫血的改善有关.
在PD患者中,HIF-PHI治疗除了通过调节脂质代谢来纠正贫血之外,还可能为PD患者带来好处.

关键词:

贫血贫血是一种疾病.最终阶段的脏疾病.缺氧诱导因子 prolyl氧酶抑制剂腹膜透析是指腹膜透析.脂质是一种脂质.

更多相关视频

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model

Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model

Published on: December 2, 2022

相关概念视频

Asymmetric Lipid Bilayer

Asymmetric Lipid Bilayer

Biological membranes show uneven distribution of different types of lipids in the inner and outer layers, resulting in transverse asymmetric membranes. The treatment of the erythrocyte membrane with the enzyme phospholipase confirmed the asymmetric nature of the lipid bilayer. The enzyme hydrolyzes lipids into fatty acids and hydrophilic groups. The phospholipase acts only on the outer layer of the membrane, while the inner layer remains intact. The phospholipase treatment resulted in 80%...